# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Viral hemorrhagic fever

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 51 results.
Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
Status: Recruiting
Last Changed: Sep 17, 2019
First Received: Jun 26, 2015
Disease(s): Viral Hemorrhagic Fever
Intervention(s): Ribavirin
Locations: Landstuhl Regional Medical Center, Landstuhl, APO Ae, Germany
Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients
Status: Recruiting
Last Changed: Jan 17, 2019
First Received: Feb 14, 2018
Disease(s): Dengue Hemorrhagic Fever
Intervention(s): Ivermectin
Locations: Faculty of Tropical Medicine Siriraj Hospital, Bangkok Noi, Bangkok, Thailand
Diagnostic of Puumala Virus Infection in France
Status: Recruiting
Last Changed: Jul 05, 2019
First Received: May 27, 2015
Disease(s): Nephropathia Epidemica, Hemorrhagic Fever With Renal Syndrome
Locations: CH Belfort-Montbéliard, Belfort, France
CHU Besançon, Besançon, France
CH Charleville Mézières, Charleville Mézières, France
CHP Sud de l'Oise, Creil, France
CHU Dijon, Dijon, France
... and 6 other locations.
Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults
Status: Recruiting
Last Changed: Dec 13, 2019
First Received: Apr 18, 2016
Disease(s): Dengue Fever, Dengue Hemorrhagic Fever, Human Immunodeficiency Virus
Intervention(s): CYD Dengue Vaccine, Placebo (NaCl 0.9%) vaccine group
Locations: Investigational Site Number 0760002, Nova Iguaçu, Rio De Janeiro, Brazil
Investigational Site Number 0760001, São Paulo, Brazil
Investigational Site Number 0760003, São Paulo, Brazil
Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
Status: Recruiting
Last Changed: Oct 21, 2019
First Received: Oct 25, 2018
Disease(s): Ebola Virus
Intervention(s): ZMapp, Remdesivir, MAb114, REGN-EB3
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Ebola Treatment Centers throughout the DRC, Kinshasa Gombe, Congo, The Democratic Republic of the
Real World Study of Classic Infectious Disease
Status: Recruiting
Last Changed: Jul 16, 2019
First Received: Jul 16, 2019
Disease(s): Brucelloses, Epidemic Hemorrhagic Fever, Kala-Azar
Intervention(s): Antibiotics
Locations: Huashan Hospital of Fudan University, Shanghai, Shanghai, China
R3470-3471-3479 Expanded Access Protocol (EAP) for Treatment of Ebola Virus
Status: Available
Last Changed: Oct 15, 2019
First Received: Jul 03, 2018
Disease(s): Ebola Virus Disease
Intervention(s): REGN3470-3471-3479
Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Dec 04, 2019
Disease(s): Ebola Virus Disease
Intervention(s): Ad26.ZEBOV vaccine
Locations: Hôpital Général de Référence de Boende, Boende, Province De La Tshuapa, Congo, The Democratic Republic of the
Ebola Vaccine Trial (Ad26.ZEBOV/MVA-BN-Filo)
Status: Recruiting
Last Changed: Aug 13, 2019
First Received: Jul 22, 2019
Disease(s): Ebola Virus Disease
Intervention(s): Ad26.ZEBOV/MVA-BN-Filo
Locations: MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda
Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC
Status: Recruiting
Last Changed: Dec 02, 2019
First Received: Nov 05, 2019
Disease(s): Ebola Virus Disease
Intervention(s): Ad26.ZEBOV, MVA-BN-Filo vaccine
Locations: L'Institut National de Recherche Biomédicale RDC, Kinshasa, Congo, The Democratic Republic of the